vs

Side-by-side financial comparison of ProFrac Holding Corp. (ACDC) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $436.5M, roughly 1.1× ProFrac Holding Corp.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -33.2%, a 23.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -4.0%). ProFrac Holding Corp. produced more free cash flow last quarter ($12.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -13.4%).

ProFrac Holding Corp. is a leading North American energy services firm that provides hydraulic fracturing, well completion, and associated support services to upstream oil and gas exploration and production operators. It primarily serves clients active across major onshore shale and conventional hydrocarbon production basins in the U.S. and Canada.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ACDC vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.1× larger
CLOV
$487.7M
$436.5M
ACDC
Growing faster (revenue YoY)
CLOV
CLOV
+48.7% gap
CLOV
44.7%
-4.0%
ACDC
Higher net margin
CLOV
CLOV
23.0% more per $
CLOV
-10.1%
-33.2%
ACDC
More free cash flow
ACDC
ACDC
$81.9M more FCF
ACDC
$12.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-13.4%
ACDC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACDC
ACDC
CLOV
CLOV
Revenue
$436.5M
$487.7M
Net Profit
$-144.7M
$-49.3M
Gross Margin
Operating Margin
-24.9%
-10.1%
Net Margin
-33.2%
-10.1%
Revenue YoY
-4.0%
44.7%
Net Profit YoY
-37.8%
-123.2%
EPS (diluted)
$-0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACDC
ACDC
CLOV
CLOV
Q4 25
$436.5M
$487.7M
Q3 25
$403.1M
$496.6M
Q2 25
$501.9M
$477.6M
Q1 25
$600.3M
$462.3M
Q4 24
$454.7M
$337.0M
Q3 24
$575.3M
$331.0M
Q2 24
$579.4M
$356.3M
Q1 24
$581.5M
$346.9M
Net Profit
ACDC
ACDC
CLOV
CLOV
Q4 25
$-144.7M
$-49.3M
Q3 25
$-100.9M
$-24.4M
Q2 25
$-105.9M
$-10.6M
Q1 25
$-17.5M
$-1.3M
Q4 24
$-105.0M
$-22.1M
Q3 24
$-45.2M
$-9.2M
Q2 24
$-66.7M
$7.4M
Q1 24
$1.8M
$-19.2M
Gross Margin
ACDC
ACDC
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
ACDC
ACDC
CLOV
CLOV
Q4 25
-24.9%
-10.1%
Q3 25
-19.5%
-4.9%
Q2 25
-10.8%
-2.2%
Q1 25
2.7%
-0.3%
Q4 24
-10.3%
-6.4%
Q3 24
-0.7%
-2.7%
Q2 24
-8.5%
2.0%
Q1 24
6.9%
-6.5%
Net Margin
ACDC
ACDC
CLOV
CLOV
Q4 25
-33.2%
-10.1%
Q3 25
-25.0%
-4.9%
Q2 25
-21.1%
-2.2%
Q1 25
-2.9%
-0.3%
Q4 24
-23.1%
-6.6%
Q3 24
-7.9%
-2.8%
Q2 24
-11.5%
2.1%
Q1 24
0.3%
-5.5%
EPS (diluted)
ACDC
ACDC
CLOV
CLOV
Q4 25
$-0.83
Q3 25
$-0.60
Q2 25
$-0.67
Q1 25
$-0.12
Q4 24
$-0.67
Q3 24
$-0.29
Q2 24
$-0.42
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACDC
ACDC
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$22.9M
$78.3M
Total DebtLower is stronger
$832.7M
Stockholders' EquityBook value
$717.5M
$308.7M
Total Assets
$2.6B
$541.0M
Debt / EquityLower = less leverage
1.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACDC
ACDC
CLOV
CLOV
Q4 25
$22.9M
$78.3M
Q3 25
$58.0M
Q2 25
$26.0M
Q1 25
$16.0M
Q4 24
$14.8M
$194.5M
Q3 24
$25.5M
$288.0M
Q2 24
$24.0M
$254.8M
Q1 24
$28.3M
$208.3M
Total Debt
ACDC
ACDC
CLOV
CLOV
Q4 25
$832.7M
Q3 25
$907.0M
Q2 25
$941.9M
Q1 25
$967.9M
Q4 24
$936.1M
Q3 24
$986.7M
Q2 24
$1.0B
Q1 24
$895.1M
Stockholders' Equity
ACDC
ACDC
CLOV
CLOV
Q4 25
$717.5M
$308.7M
Q3 25
$862.0M
$340.9M
Q2 25
$875.5M
$344.2M
Q1 25
$988.1M
$336.1M
Q4 24
$1.0B
$341.1M
Q3 24
$1.1B
$342.2M
Q2 24
$1.1B
$324.9M
Q1 24
$1.2B
$292.5M
Total Assets
ACDC
ACDC
CLOV
CLOV
Q4 25
$2.6B
$541.0M
Q3 25
$2.7B
$559.7M
Q2 25
$2.8B
$575.0M
Q1 25
$3.0B
$583.7M
Q4 24
$3.0B
$580.7M
Q3 24
$3.1B
$653.0M
Q2 24
$3.2B
$674.2M
Q1 24
$3.0B
$671.8M
Debt / Equity
ACDC
ACDC
CLOV
CLOV
Q4 25
1.16×
Q3 25
1.05×
Q2 25
1.08×
Q1 25
0.98×
Q4 24
0.93×
Q3 24
0.90×
Q2 24
0.88×
Q1 24
0.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACDC
ACDC
CLOV
CLOV
Operating Cash FlowLast quarter
$49.5M
$-66.9M
Free Cash FlowOCF − Capex
$12.9M
$-69.0M
FCF MarginFCF / Revenue
3.0%
-14.1%
Capex IntensityCapex / Revenue
8.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$19.6M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACDC
ACDC
CLOV
CLOV
Q4 25
$49.5M
$-66.9M
Q3 25
$900.0K
$12.1M
Q2 25
$100.4M
$5.4M
Q1 25
$38.7M
$-16.3M
Q4 24
$76.5M
$34.8M
Q3 24
$98.2M
$50.0M
Q2 24
$113.5M
$44.8M
Q1 24
$79.1M
$25.9M
Free Cash Flow
ACDC
ACDC
CLOV
CLOV
Q4 25
$12.9M
$-69.0M
Q3 25
$-33.4M
$11.4M
Q2 25
$53.9M
$4.8M
Q1 25
$-13.8M
$-16.5M
Q4 24
$13.3M
$33.3M
Q3 24
$28.2M
$49.6M
Q2 24
$51.6M
$44.4M
Q1 24
$19.2M
$25.5M
FCF Margin
ACDC
ACDC
CLOV
CLOV
Q4 25
3.0%
-14.1%
Q3 25
-8.3%
2.3%
Q2 25
10.7%
1.0%
Q1 25
-2.3%
-3.6%
Q4 24
2.9%
9.9%
Q3 24
4.9%
15.0%
Q2 24
8.9%
12.5%
Q1 24
3.3%
7.3%
Capex Intensity
ACDC
ACDC
CLOV
CLOV
Q4 25
8.4%
0.4%
Q3 25
8.5%
0.1%
Q2 25
9.3%
0.1%
Q1 25
8.7%
0.0%
Q4 24
13.9%
0.5%
Q3 24
12.2%
0.1%
Q2 24
10.7%
0.1%
Q1 24
10.3%
0.1%
Cash Conversion
ACDC
ACDC
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24
43.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACDC
ACDC

Services$385.6M88%
Products$50.9M12%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons